| Wang, Jianan |
NCT05260411: A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia |
|
|
| Recruiting | 3 | 240 | RoW | AK102, Placebo | Akeso | Hyperlipidemia | 06/22 | 12/22 | | |
| Completed | 3 | 226 | Europe, Canada, US, RoW | Bentracimab (PB2452) Infusion | SFJ Pharmaceuticals, Inc. | Hemorrhage, Urgent Surgery, Invasive Procedure | 09/24 | 09/24 | | |
NCT05212454: Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks |
|
|
| Recruiting | 3 | 400 | RoW | Capecitabine | Second Affiliated Hospital, School of Medicine, Zhejiang University | Breast Cancer, Chemotherapy Effect | 12/25 | 12/29 | | |
NCT06109831: Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic |
|
|
| Active, not recruiting | 2 | 335 | RoW | SHR-1918, SHR-1918 placebo | Beijing Suncadia Pharmaceuticals Co., Ltd | Hyperlipidemic | 10/24 | 09/25 | | |
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 539 | RoW | BuMA Supreme, BuMA™ | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 03/18 | 12/25 | | |
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 1000 | RoW | BuMA Supreme | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 05/19 | 12/25 | | |
NCT05888246: Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram |
|
|
| Completed | N/A | 412 | RoW | Magnetocardiogram | Hangzhou Nuochi Life Science Co., Ltd. | Healthy People | 05/22 | 05/22 | | |
NCT04921605: Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation |
|
|
| Enrolling by invitation | N/A | 10 | RoW | DragonFly transcatheter mitral valve clamping system | Hangzhou Valgen Medtech Co., Ltd | Tricuspid Regurgitation | 09/22 | 06/23 | | |
| Enrolling by invitation | N/A | 20 | RoW | Dragonfly mitral valve repair system | Hangzhou Valgen Medtech Co., Ltd | Mitral Regurgitation | 12/22 | 12/23 | | |
NCT05375110: NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) |
|
|
| Recruiting | N/A | 120 | RoW | NoYAâ„¢ Radiofrequency Interatrial Shunt System | Hangzhou NOYA MedTech Co. Ltm. | Heart Failure | 12/22 | 12/23 | | |
| Active, not recruiting | N/A | 52 | RoW | Medtronic CoreValve™ Evolut™ PRO System | Medtronic Cardiovascular | Severe, Symptomatic Aortic Stenosis | 03/23 | 05/28 | | |
| Recruiting | N/A | 120 | RoW | Transcatheter aortic valve replacement | Genesis Medtech Corporation | Diseases of Aortic Valve, Aortic Regurgitation Disease | 05/23 | 05/24 | | |
NCT05607667: Clinical Trial in China for Aortic Valve Stenosis |
|
|
| Recruiting | N/A | 53 | RoW | Transcatheter aortic valve replacement | Genesis Medtech Corporation | Diseases of Aortic Valve, Aortic Stenosis Disease | 05/23 | 05/23 | | |
NCT04734756: Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation |
|
|
| Enrolling by invitation | N/A | 120 | RoW | Dragonfly Transcatheter Mitral Valve Repair System | Hangzhou Valgen Medtech Co., Ltd | Degenerative Mitral Valve Disease | 05/23 | 05/27 | | |
NCT04733404: Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation |
|
|
| Recruiting | N/A | 120 | RoW | Dragonfly Transcatheter Mitral Valve Repair System | Hangzhou Valgen Medtech Co., Ltd | Mitral Regurgitation Functional | 09/23 | 09/27 | | |
| Recruiting | N/A | 876 | RoW | Perclose Proglide system | Second Affiliated Hospital, School of Medicine, Zhejiang University | Severe Aortic Stenosis | 01/26 | 02/26 | | |
| Enrolling by invitation | N/A | 239 | RoW | Coronary atherectomy system of Shanghai MicroPort Rhythm, Stenting will be applied in both arms, Rotablator Rotational Atherectomy System | Shanghai MicroPort Rhythm MedTech Co., Ltd. | Calcification of Coronary Artery | 12/23 | 12/24 | | |
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) |
|
|
| Recruiting | N/A | 116 | RoW | TaurusTrio™ Heart Valve System | Peijia Medical Technology (Suzhou) Co., Ltd. | Aortic Regurgitation | 07/24 | 07/29 | | |
FLAVOUR II, NCT04397211: Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease |
|
|
| Active, not recruiting | N/A | 1872 | RoW | Angiography-derived FFR, IVUS | Second Affiliated Hospital, School of Medicine, Zhejiang University, Seoul National University Hospital, Affiliated Hangzhou First People's Hospital, Wuhan University, Peking University Third Hospital, The Affiliated Hospital of Hangzhou Normal University, RenJi Hospital, Second Hospital of Shanxi Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Changxing People's Hospital, The Affiliated Hospital of Medical College, Ningbo University, Jinhua Central Hospital, Shandong University of Traditional Chinese Medicine, Dongyang People's Hospital, The First Affiliated Hospital of Nanchang University, Jining First People's Hospital, Second Affiliated Hospital of Shantou University Medical College, Ulsan University Hospital, Huizhou Municipal Central Hospital, Zhejiang Greentown Cardiovascular Hospital, The Fourth People's Hospital of Jinan, First Affiliated Hospital of Kunming Medical University | Coronary Artery Disease | 09/24 | 09/28 | | |
NCT06595992: Prospective Observational Cohort Study of Moderate Aortic Valve Disease |
|
|
| Recruiting | N/A | 1000 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University | Moderate Aortic Valve Stenosis, Moderate Aortic Valve Regurgitation, Aortic Valve Disease | 01/34 | 01/34 | | |
AFMR, NCT06630936: Study of Atrial Fibrillation Combined with Atrial Functional Mitral Regurgitation |
|
|
| Recruiting | N/A | 500 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University | Atrial Fibrillation (AF), Atrial Functional Mitral Regurgitation | 05/26 | 09/26 | | |
STEMI, NCT04929158: Comparison of Clinical Outcomes of IVUS -Guided and Angiography-guided PCI in Patients With Acute |
|
|
| Available | N/A | 200 | RoW | Intravascular Ultrasound (IVUS) -guided Primary Percutaneous Intervention (PCI), Angiography-guided Primary Percutaneous Intervention (PCI) | Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Changxing People's Hospital | ST Elevation Myocardial Infarction | | | | |
VITAL, NCT05977257: VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （） |
|
|
| Not yet recruiting | N/A | 89 | RoW | VitaFlow® Transcatheter Aortic Valve Replacement System | Shanghai MicroPort CardioFlow Medtech Co., Ltd. | Aortic Valve Disease, Aortic Valve Stenosis | 10/25 | 10/28 | | |
TRAVEL, NCT04436653: THE TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve |
|
|
| Recruiting | N/A | 150 | RoW | Tricuspid Valve Replacement System | Changhai Hospital, Fu Wai Hospital, Beijing, China, Beijing Anzhen Hospital, Wuhan Union Hospital, China, West China Hospital, Xijing Hospital, Guangdong Provincial People's Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University | Tricuspid Valve Insufficiency | 06/26 | 06/26 | | |
NCT05194423: THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein |
|
|
| Recruiting | N/A | 150 | RoW | Tricuspid Valve Replacement System via jugular vein | Changhai Hospital, Shanghai Zhongshan Hospital, Fu Wai Hospital, Beijing, China, Beijing Anzhen Hospital, Wuhan Union Hospital, China, West China Hospital, Xijing Hospital, Guangdong Provincial People's Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University | Tricuspid Valve Regurgitation | 03/27 | 03/27 | | |
NCT04922541: Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up |
|
|
| Recruiting | N/A | 50 | RoW | PD-1 inhibitor | Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Cancer Hospital, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Sun Yat-sen University, Ningbo Medical Center Lihuili Hospital, Ningbo No.2 Hospital, Huizhou Municipal Central Hospital | Plaque, Atherosclerotic, Programmed Cell Death Protein 1 Inhibitor | 06/22 | 12/22 | | |
NCT05251987: Comparison of PD1+T Cell Expression in Peripheral Blood for Cardiac Function Prognosis in Patients With Acute MI |
|
|
| Recruiting | N/A | 100 | RoW | PD1+ T Cell Expression | Second Affiliated Hospital, School of Medicine, Zhejiang University, First People's Hospital of Hangzhou | PD1, Acute Myocardial Infarction | 06/22 | 12/22 | | |
NCT05123287: A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up |
|
|
| Recruiting | N/A | 50 | RoW | PD-1 immune checkpoint blockades | Second Affiliated Hospital, School of Medicine, Zhejiang University | Plaque, Atherosclerotic, Immune Checkpoint Inhibitors, Programmed Cell Death Protein 1 Inhibitor, Carotid Artery Plaque, Intimal Medial Thickness of Internal Carotid Artery | 06/22 | 12/22 | | |
NCT05549336: Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients |
|
|
| Recruiting | N/A | 100 | RoW | PD-1 inhibitor, PD-1 immune checkpoint blockades | Second Affiliated Hospital, School of Medicine, Zhejiang University | Carotid Artery Plaque, Pd-1 Inhibitors | 06/23 | 09/23 | | |
